Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 491

Related Citations for PubMed (Select 9703911)

1.

Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.

Teicher BA, Williams JI, Takeuchi H, Ara G, Herbst RS, Buxton D.

Anticancer Res. 1998 Jul-Aug;18(4A):2567-73.

PMID:
9703911
2.

Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.

Teicher BA, Holden SA, Ara G, Dupuis NP, Goff D.

Cancer J Sci Am. 1995 May-Jun;1(1):43-8.

PMID:
9166453
3.

Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies.

Williams JI, Weitman S, Gonzalez CM, Jundt CH, Marty J, Stringer SD, Holroyd KJ, Mclane MP, Chen Q, Zasloff M, Von Hoff DD.

Clin Cancer Res. 2001 Mar;7(3):724-33.

4.

beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.

Teicher BA, Sotomayor EA, Huang ZD, Ara G, Holden S, Khandekar V, Chen YN.

Cancer Chemother Pharmacol. 1993;33(3):229-38.

PMID:
8269604
5.

PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy.

Teicher BA, Ara G, Herbst R, Takeuchi H, Keyes S, Northey D.

In Vivo. 1997 Jul-Aug;11(4):301-11.

PMID:
9292296
7.
8.

Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing.

Teicher BA, Sotomayor EA, Dupuis NP, Kusumoto T, Menon K.

J Cancer Res Clin Oncol. 1994;120(10):593-8.

PMID:
7929530
9.

Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma.

Teicher BA, Holden SA, Ara G, Korbut T, Menon K.

Cancer Chemother Pharmacol. 1996;38(2):169-77.

PMID:
8616908
10.

Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma.

Teicher BA, Ara G, Buxton D, Leonard J, Schaub RG.

Radiat Oncol Investig. 1998;6(2):71-80.

PMID:
9572683
11.

CAI: effects on cytotoxic therapies in vitro and in vivo.

Teicher BA, Holden SA, Chen YN, Ara G, Korbut TT, Northey D.

Cancer Chemother Pharmacol. 1994;34(6):515-21.

PMID:
7923563
12.
13.

Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model.

Sigounas G, Sallah S, Sigounas VY.

Cancer Lett. 2004 Oct 28;214(2):171-9.

PMID:
15363543
14.

Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.

Teicher BA, Dupuis NP, Robinson MF, Kusumoto T, Liu M, Menon K.

In Vivo. 1994 Jan-Feb;8(1):125-31.

PMID:
8054502
15.

Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma.

Tofani S, Barone D, Berardelli M, Berno E, Cintorino M, Foglia L, Ossola P, Ronchetto F, Toso E, Eandi M.

Pharmacol Res. 2003 Jul;48(1):83-90.

PMID:
12770519
16.

Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.

Dupuis NP, Kusumoto T, Robinson MF, Liu F, Menon K, Teicher BA.

Artif Cells Blood Substit Immobil Biotechnol. 1995;23(3):423-9.

PMID:
7493063
17.

Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in murine lewis lung carcinoma and human Calu-6 non-small-cell lung carcinoma xenografts.

Teicher BA, Menon K, Alvarez E, Galbreath E, Shih C, Faul MM.

Cancer Chemother Pharmacol. 2001 Dec;48(6):473-80.

PMID:
11800028
18.

Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.

Donnelly ET, Kelley M, Rockwell S.

Cancer Chemother Pharmacol. 2004 Jan;53(1):43-50. Epub 2003 Oct 22.

PMID:
14574460
19.

A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

Herbst RS, Hammond LA, Carbone DP, Tran HT, Holroyd KJ, Desai A, Williams JI, Bekele BN, Hait H, Allgood V, Solomon S, Schiller JH.

Clin Cancer Res. 2003 Sep 15;9(11):4108-15.

20.

PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.

Yuan Z, Yan F, Wang YS, Liu HY, Gou LT, Zhao XY, Lai ST, Deng HX, Li J, Ding ZY, Xiong SQ, Kan B, Mao YQ, Chen LJ, Wei YQ, Zhao X.

Cancer Chemother Pharmacol. 2009 Dec;65(1):13-25. doi: 10.1007/s00280-009-0998-5. Epub 2009 Apr 22.

PMID:
19387645
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk